Bandingkan Harga & Kinerja Prodia Widyahusada Tbk. (PRDA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Prodia Widyahusada Tbk. dan Organon Pharma Indonesia Tbk.: Prodia Widyahusada Tbk. diperdagangkan di Rp2.810 (kapitalisasi pasar 2,63 T, volume 24 jam 861,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Prodia Widyahusada Tbk. jauh lebih besar — sekitar 25,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PRDA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,63 T | 104,4 M |
Volume | 861,1 rb | — |
Lot | 8,61 rb | — |
Perputaran | 2,42 M | — |
Harga Rata-rata | 2.806,54 | — |
Nilai Transaksi | 2,42 M | — |
Harga Ekuilibrium Indikatif | 2.810 | — |
Volume Ekuilibrium Indikatif | 713 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Prodia Widyahusada Tbk.
PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Selengkapnya di halaman PRDA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
